Haiyan Li

3.8k total citations · 1 hit paper
76 papers, 2.6k citations indexed

About

Haiyan Li is a scholar working on Surgery, Molecular Biology and Pharmacology. According to data from OpenAlex, Haiyan Li has authored 76 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 15 papers in Molecular Biology and 14 papers in Pharmacology. Recurrent topics in Haiyan Li's work include Diabetes Treatment and Management (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Haiyan Li is often cited by papers focused on Diabetes Treatment and Management (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Haiyan Li collaborates with scholars based in China, United States and United Kingdom. Haiyan Li's co-authors include Dongyang Liu, Cheng Cui, Xueting Yao, Chunli Song, Miao Zhang, Erdan Dong, Fei Ye, Xu Liu, Siyan Zhan and Peihua Niu and has published in prestigious journals such as Nature Communications, Journal of the American College of Cardiology and Clinical Infectious Diseases.

In The Last Decade

Haiyan Li

67 papers receiving 2.5k citations

Hit Papers

In Vitro Antiviral Activity and Projection of Optimized D... 2020 2026 2022 2024 2020 500 1000 1.5k

Peers

Haiyan Li
Cheng Cui China
Darius Babusis United States
Ming Yang China
James M. Sanders United States
Cheng Cui China
Haiyan Li
Citations per year, relative to Haiyan Li Haiyan Li (= 1×) peers Cheng Cui

Countries citing papers authored by Haiyan Li

Since Specialization
Citations

This map shows the geographic impact of Haiyan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyan Li more than expected).

Fields of papers citing papers by Haiyan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiyan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyan Li. The network helps show where Haiyan Li may publish in the future.

Co-authorship network of co-authors of Haiyan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Haiyan Li. A scholar is included among the top collaborators of Haiyan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyan Li. Haiyan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fangfang, et al.. (2025). A Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of Posdinemab (JNJ‐63733657) in Healthy Chinese Adults. The Journal of Clinical Pharmacology. 66(2). e70116–e70116.
2.
Li, Wenjing, Haiyan Li, Liangliang Fan, et al.. (2025). The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases. International Journal of Nanomedicine. Volume 20. 12627–12658.
3.
Wang, Fangfang, et al.. (2025). Safety, pharmacokinetics and pharmacodynamics of Plozasiran in Chinese healthy volunteers. Cardiovascular Diabetology. 24(1). 399–399.
4.
Li, Haiyan, Dawei Gao, Lu Wang, et al.. (2025). Composition, physicochemical property and stability of canola seed oil: Impact of different pretreatment. Food Bioscience. 64. 105933–105933. 3 indexed citations
6.
Zhang, Yuling, Weiling Leng, Ying Li, et al.. (2024). Association between serum β2‐microglobulin and left ventricular hypertrophy in patients with type 2 diabetes mellitus: A cross‐sectional study. Journal of Diabetes. 16(8). e13599–e13599. 3 indexed citations
7.
Liu, Na, Xiaohong Wang, Jixiang Zhu, et al.. (2023). A single- and multiple-dose study to characterize the pharmacokinetics, safety, and tolerability of ceftolozane/tazobactam in healthy Chinese participants. International Journal of Antimicrobial Agents. 61(3). 106717–106717. 2 indexed citations
8.
Zhang, Miao, Huan Liu, Xu Wang, et al.. (2023). Model‐informed drug development: The mechanistic HSK3486 physiologically based pharmacokinetic model informing dose decisions in clinical trials of specific populations. Biopharmaceutics & Drug Disposition. 44(3). 259–273. 8 indexed citations
9.
Zhang, Miao, et al.. (2023). Development of a PBPK model to quantitatively understand absorption and disposition mechanism and support future clinical trials for PB‐201. CPT Pharmacometrics & Systems Pharmacology. 12(7). 941–952. 4 indexed citations
10.
Hai, M. T. Vu, et al.. (2023). Physiologically Based Pharmacokinetic Model for Older Adults and Its Application in Geriatric Drug Research. Current Drug Metabolism. 24(3). 211–222. 5 indexed citations
11.
Liu, Xu, Hongzhong Liu, Haiyan Li, et al.. (2021). Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes. Frontiers in Endocrinology. 12. 694390–694390. 4 indexed citations
12.
Liu, Qi, Guiying Chen, Xiaolin Tong, et al.. (2021). Time-Dependent Distribution of Hydroxychloroquine in Cynomolgus Macaques Using Population Pharmacokinetic Modeling Method. Frontiers in Pharmacology. 11. 602880–602880. 8 indexed citations
13.
Li, Haiyan, Yudong Wei, Zhenhua Yang, et al.. (2020). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study. American Journal of Cardiovascular Drugs. 20(5). 489–503. 6 indexed citations
14.
Li, Haiyan, et al.. (2020). Effects of Flag Leaf and Number of Vegetative Ramets on Sexual Reproductive Performance in the Clonal Grass Leymus chinensis. Frontiers in Plant Science. 11. 534278–534278. 11 indexed citations
15.
Wang, Ming, Gang Liu, & Haiyan Li. (2017). Curative effects of shikonin on allergic rhinitis in rats and the related mechanism. Biomedical Research-tokyo. 28(21). 9253–9257. 1 indexed citations
16.
Gummesson, Anders, Haiyan Li, Michael Gillen, et al.. (2014). Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Chinese Subjects. Clinical Drug Investigation. 34(11). 763–772. 4 indexed citations
17.
Li, Haiyan, Yunfei Yang, & Yu Zhao. (2012). Bud banks of two dominant grass species and their roles in restoration succession series of a flooded meadow. Polish Journal of Ecology. 60(3). 535–543. 6 indexed citations
18.
Li, Haiyan & Yang Yun-fei. (2011). Bud banks of two perennial grasses: Composition, size, dynamics and contribution to population maintenance during the flooded restoration succession on the Songnen Meadow, China. African Journal of Agricultural Research. 6(10). 2198–2203. 6 indexed citations
19.
Li, Haiyan, Kõji Tanaka, Hitoshi Anzai, et al.. (2006). Influence of Pre-Existing Donor Atherosclerosis on the Development of Cardiac Allograft Vasculopathy and Outcomes in Heart Transplant Recipients. Journal of the American College of Cardiology. 47(12). 2470–2476. 55 indexed citations
20.
Li, Haiyan. (2005). Effect of Different Ultrasonic Frequencies on Extraction Rate of Berberine Chloride from Phellodendron chinese Schneid. Lishizhen Medicine and Materia Medica Research. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026